UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Lincoln Capital Corp

Lincoln Capital Corp decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 31.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,291 shares of the healthcare conglomerate's stock after selling 4,332 shares during the period. UnitedHealth Group accounts for about 2.0% of Lincoln Capital Corp's portfolio, making the stock its 16th biggest position. Lincoln Capital Corp's holdings in UnitedHealth Group were worth $4,866,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of UNH. Financial Management Professionals Inc. raised its stake in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares during the period. Richwood Investment Advisors LLC raised its position in UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after acquiring an additional 20 shares during the period. Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after acquiring an additional 20 shares during the period. Kolinsky Wealth Management LLC raised its stake in UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after acquiring an additional 21 shares during the period. Finally, Retirement Planning Group LLC increased its stake in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after purchasing an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Up 0.4%

UnitedHealth Group stock traded up $1.13 during midday trading on Friday, reaching $308.69. The company's stock had a trading volume of 6,161,145 shares, compared to its average volume of 7,543,771. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $280.03 billion, a P/E ratio of 12.93, a PEG ratio of 1.46 and a beta of 0.45. The stock's 50-day simple moving average is $327.18 and its 200-day simple moving average is $448.90.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. Robert W. Baird cut UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target on the stock. in a report on Wednesday, June 11th. Truist Financial reissued a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Mizuho dropped their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Finally, KeyCorp reduced their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $415.57.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.